(UL) Unilever - Overview
Stock: Shampoo, Soap, Deodorant, Detergent, Seasoning
Dividends
| Dividend Yield | 3.20% |
| Yield on Cost 5y | 3.68% |
| Yield CAGR 5y | -0.05% |
| Payout Consistency | 91.9% |
| Payout Ratio | 1.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 20.8% |
| Relative Tail Risk | -5.46% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.54 |
| Alpha | 9.31 |
| Character TTM | |
|---|---|
| Beta | 0.011 |
| Beta Downside | -0.244 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.93% |
| CAGR/Max DD | 0.78 |
Description: UL Unilever January 27, 2026
Unilever PLC (NYSE: UL) is a global fast-moving consumer goods (FMCG) group that sells a diversified portfolio of brands across four operating segments-Beauty & Wellbeing, Personal Care, Home Care, and Foods-in more than 190 markets spanning Asia-Pacific, Africa, the Americas and Europe.
In FY 2023 the company generated €60.1 billion of underlying sales, growing 2.2% YoY on a constant-currency basis, with an operating margin of 17.5% and a net-debt-to-EBITDA ratio of 1.9×, reflecting steady cash-flow generation despite higher commodity costs. The dividend payout remained at 3.3% of the share price, underscoring a commitment to shareholder returns.
Key drivers of Unilever’s performance include: (1) inflation-adjusted consumer spending trends in emerging markets, where per-capita income growth of ~5% YoY is boosting demand for affordable personal-care and home-care products; (2) a continued shift toward sustainable and “clean-label” offerings, with the Beauty & Wellbeing segment posting a 4.1% sales premium on products certified with the company’s “Sustainable Living” label; and (3) accelerating e-commerce penetration, which now accounts for roughly 12% of total sales and is growing at 15% annually, outpacing the broader FMCG sector.
For a deeper, data-driven assessment of Unilever’s valuation relative to peers, consider exploring the analytics platform ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 12.20b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.19 > 0.02 and ΔFCF/TA 5.47 > 1.0 |
| NWC/Revenue: -4.92% < 20% (prev -6.18%; Δ 1.26% < -1%) |
| CFO/TA 0.24 > 3% & CFO 17.87b > Net Income 12.20b |
| Net Debt (28.91b) to EBITDA (24.56b): 1.18 < 3 |
| Current Ratio: 0.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.45b) vs 12m ago -3.02% < -2% |
| Gross Margin: 43.51% > 18% (prev 0.24%; Δ 4327 % > 0.5%) |
| Asset Turnover: 158.7% > 50% (prev 120.5%; Δ 38.27% > 0%) |
| Interest Coverage Ratio: 13.98 > 6 (EBITDA TTM 24.56b / Interest Expense TTM 1.56b) |
Altman Z'' -2.26
| A: -0.08 (Total Current Assets 19.19b - Total Current Liabilities 25.10b) / Total Assets 76.00b |
| B: -0.46 (Retained Earnings -35.14b / Total Assets 76.00b) |
| C: 0.29 (EBIT TTM 21.77b / Avg Total Assets 75.63b) |
| D: -2.08 (Book Value of Equity -120.89b / Total Liabilities 58.20b) |
| Altman-Z'' Score: -2.26 = D |
Beneish M -2.93
| DSRI: 1.44 (Receivables 7.69b/4.02b, Revenue 120.06b/90.68b) |
| GMI: 0.55 (GM 43.51% / 23.98%) |
| AQI: 0.97 (AQ_t 0.60 / AQ_t-1 0.62) |
| SGI: 1.32 (Revenue 120.06b / 90.68b) |
| TATA: -0.07 (NI 12.20b - CFO 17.87b) / TA 76.00b) |
| Beneish M-Score: -2.93 (Cap -4..+1) = A |
What is the price of UL shares?
Over the past week, the price has changed by +5.50%, over one month by +11.85%, over three months by +6.01% and over the past year by +13.88%.
Is UL a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the UL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 70.4 | -2.4% |
| Analysts Target Price | 70.4 | -2.4% |
| ValueRay Target Price | 78.9 | 9.4% |
UL Fundamental Data Overview February 05, 2026
P/E Trailing = 23.2828
P/E Forward = 18.0505
P/S = 2.5243
P/B = 6.9947
P/EG = 2.0513
Revenue TTM = 120.06b EUR
EBIT TTM = 21.77b EUR
EBITDA TTM = 24.56b EUR
Long Term Debt = 24.87b EUR (from longTermDebt, last quarter)
Short Term Debt = 7.16b EUR (from shortTermDebt, last quarter)
Debt = 32.02b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 28.91b EUR (from netDebt column, last quarter)
Enterprise Value = 158.59b EUR (127.80b + Debt 32.02b - CCE 1.23b)
Interest Coverage Ratio = 13.98 (Ebit TTM 21.77b / Interest Expense TTM 1.56b)
EV/FCF = 10.96x (Enterprise Value 158.59b / FCF TTM 14.47b)
FCF Yield = 9.13% (FCF TTM 14.47b / Enterprise Value 158.59b)
FCF Margin = 12.05% (FCF TTM 14.47b / Revenue TTM 120.06b)
Net Margin = 10.16% (Net Income TTM 12.20b / Revenue TTM 120.06b)
Gross Margin = 43.51% ((Revenue TTM 120.06b - Cost of Revenue TTM 67.82b) / Revenue TTM)
Gross Margin QoQ = none% (prev -12.64%)
Tobins Q-Ratio = 2.09 (Enterprise Value 158.59b / Total Assets 76.00b)
Interest Expense / Debt = 1.18% (Interest Expense 377.0m / Debt 32.02b)
Taxrate = 25.17% (1.28b / 5.09b)
NOPAT = 16.29b (EBIT 21.77b * (1 - 25.17%))
Current Ratio = 0.76 (Total Current Assets 19.19b / Total Current Liabilities 25.10b)
Debt / Equity = 1.80 (Debt 32.02b / totalStockholderEquity, last quarter 17.79b)
Debt / EBITDA = 1.18 (Net Debt 28.91b / EBITDA 24.56b)
Debt / FCF = 2.00 (Net Debt 28.91b / FCF TTM 14.47b)
Total Stockholder Equity = 19.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.12% (Net Income 12.20b / Total Assets 76.00b)
RoE = 64.03% (Net Income TTM 12.20b / Total Stockholder Equity 19.05b)
RoCE = 49.58% (EBIT 21.77b / Capital Employed (Equity 19.05b + L.T.Debt 24.87b))
RoIC = 49.16% (NOPAT 16.29b / Invested Capital 33.14b)
WACC = 4.94% (E(127.80b)/V(159.82b) * Re(5.96%) + D(32.02b)/V(159.82b) * Rd(1.18%) * (1-Tc(0.25)))
Discount Rate = 5.96% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.52%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈12.77b ; Y1≈15.75b ; Y5≈26.83b
Fair Price DCF = 345.0 (EV 781.34b - Net Debt 28.91b = Equity 752.43b / Shares 2.18b; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -11.90 | EPS CAGR: -61.30% | SUE: 0.0 | # QB: 0
Revenue Correlation: 12.45 | Revenue CAGR: 6.40% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=3.09 | Chg30d=-0.012 | Revisions Net=+0 | Growth EPS=+5.1% | Growth Revenue=+1.9%